technology — US PTAB Patent Cases
666 decisions indexed
Page 5 of 23 · 666 total
Jesco Lighting Group, LLC v.AGS Lighting Management, LLC
The PTAB granted institution for IPR2025-01328 after finding the petitioner had a reasonable likelihood of prevailing. The proceeding is currently stayed pending review in another case.
Capital One, N.A. et al. v.Wapp Tech Corp. et al.
Capital One seeks PTAB Director Review of its IPR against Wapp Tech, with a brief response window for the patent owner.
UNION ELECTRIC COMPANY et al. v.MES, Inc.
Union Electric filed Director Review requests for IPR2025-01322, -01323, and -01324. The PTAB Director instructed MES, Inc. to respond within five business days, limited to 15 pages and no new evidence.
3D Systems Corporation et al. v.Intrepid Automation, Inc.
The USPTO granted institution for five IPR proceedings (IPR2025-01042, IPR2025-01241, IPR2025-01264, IPR2025-01153, and IPR2025-01242) after determining the petitioner had a reasonable likelihood of prevailing.
Fresenius Kabi SwissBioSim GmbH et al. v.Regeneron Pharmaceuticals, Inc.
Court decision.
Disney Entertainment & Sports LLC v.Adeia Technologies Inc.
Disney filed an unopposed motion to dismiss its inter partes review of Adeia’s U.S. Patent 9,235,428 before the Board institutes the case, arguing that the proceeding is at an early stage and dismissal would save resources.
NIUM PTE. LTD. v.Intercurrency Software LLC
NIUM PTE. Ltd. and Intercurrency Software LLC settled their IPR dispute before trial. The Board granted the joint motion to terminate, dismissing the petition.
GENERAC POWER SYSTEMS, INC. et al. v.Champion Power Equipment, Inc.
The PTAB granted institution for IPR2025-01457 after reviewing the petitioner's likelihood of prevailing. This allows the case to move forward to a merits trial.
Volex plc v.CREDO TECHNOLOGY GROUP LTD.
Volex PLC and Credo Technology Group settled their IPR disputes covering three patents, including U.S. Patent 11,012,252, and jointly moved to terminate the proceedings. The Board granted the termination and treated the settlement agreement as confidential.
Marvell Semiconductor, Inc. v.Credo Technology Group Ltd.
The PTAB granted institution for IPR2025-01219, allowing Marvell Semiconductor to challenge Credo Technology Group's patent 11012252.
Ascend Elements, Inc. v.Duesenfeld GmbH
Petition for inter partes review of U.S. Patent 12,119,463 filed by Ascend Elements against Duesenfeld GmbH.
Advanced Micro Devices, Inc. et al. v.Concurrent Ventures, LLC et al.
The USPTO denied AMD and Pensando's request for rehearing of a Director discretionary denial in IPR2025-00478 concerning patent 8,924,596. The order affirms the original decision without further review.
Apple Inc. v.Advanced Coding Technologies LLC
The USPTO Board denied institution of multiple IPRs, including the proceeding involving Apple Inc. and Advanced Coding Technologies LLC.
Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.
The PTAB granted institution for IPR2025-01164, allowing Samsung to proceed against Wilus regarding patent 12004262. The Board found a reasonable likelihood of prevailing.
Apple Inc. v.Vampire Labs, LLC
Apple and Vampire Labs have reached a settlement that resolves all disputes over U.S. Patent 8,358,103, and they have jointly moved to terminate the pending IPR.
CentralSquare Technologies, LLC v.Carbyne, Ltd. et al.
CentralSquare (CST) opposes Carbyne’s request for a good‑cause extension to seek Director Review in IPR2025‑01179, asserting the deadline was missed intentionally and no claim‑construction conflict exists. The email urges the Director to deny the contingent request.
Apple Inc. v.Vampire Labs, LLC
Apple and Vampire Labs reached a settlement, prompting a joint motion that led the PTAB to terminate the inter partes review of patent 8,358,103. The Board granted the termination without addressing the merits.
Apple Inc. v.Vampire Labs, LLC
Apple and Vampire Labs filed a joint motion asking the PTAB to treat their settlement agreement as business‑confidential and to terminate the IPR.
CentralSquare Technologies, LLC v.Carbyne, Ltd. et al.
The USPTO denied Carbyne’s request for an extension to file a Director Review, finding no good cause and citing Revvo precedent. CentralSquare’s claim‑construction positions were already known before the deadline.
Aerin Medical Inc. v.Neurent Medical Ltd. et al.
The USPTO Office Director denied institution of inter partes review (IPR2025-01127) for the challenged patent, meaning no trial will proceed on the claims.
Perfect Corporation v.Zugara, Inc.
Perfect Corp. and Zugara, Inc. settled their IPR dispute over patent 10,482,517. The Board granted a joint motion to terminate the proceeding and kept the settlement agreement confidential.
Aerin Medical Inc. v.Neurent Medical Ltd. et al.
The USPTO Director denied institution for several Inter Partes Review (IPR) petitions, including IPR2025-01126. This procedural denial means no trial will be held on the challenged patents.
Samsung Electronics Co., Ltd. et al. v.Wilus Institute of Standards and Technology Inc.
The PTAB granted institution for IPR2025-01165, allowing Samsung Electronics to proceed with challenging Wilus Institute's patent. The Board found a reasonable likelihood of prevailing on at least one claim.
Starbucks Corporation et al. v.Pi-Design AG et al.
Starbucks and Pi‑Design have settled their IPR dispute over U.S. Patent 8,695,486 and jointly seek to keep the settlement confidential under statutory provisions.
Harbor Freight Tools USA, Inc. et al. v.Champion Power Equipment, Inc.
Court decision.
Harbor Freight Tools USA, Inc. et al. v.Champion Power Equipment, Inc.
The PTAB denied institution of IPR2025-01121 in the dispute between Harbor Freight Tools and Champion Power Equipment because the petitioner failed to demonstrate a reasonable likelihood of prevailing.
Infineon Technologies Americas Corp. et al. v.MOSAID Technologies Inc.
The PTAB notified the parties that a Director Review request has been filed in IPR2025-01171 over patent 7,051,306. The petitioner has five business days to submit a limited response; no new evidence is allowed.
Conjupro Biotherapeutics, Inc. et al. v.Ascletis Pharma China Co. Ltd.
The PTAB granted institution for PGR2025-00057, allowing the challenger to proceed with trial against patent 12234236.
Aerin Medical Inc. v.Neurent Medical Ltd. et al.
The USPTO Director denied institution for the IPR proceedings involving Aerin Medical Inc. and Neurent Medical Ltd., halting further trial.
Google LLC v.Advanced Coding Technologies LLC
Google has filed a Petition for Director Review challenging the USPTO Director’s denial of institution for patent 7,804,891, alleging statutory and procedural violations.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.